Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.
|
|
- Paula Rogers
- 1 years ago
- Views:
Transcription
1 Prescribing and Dispensing Profile Minnesota Research current through November This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the Office of National Drug Control Policy or the United States Government. 1
2 Schedule II Prescribing Limitations (not related to pain clinics) Schedule II substances can only be dispensed on the written prescription of a practitioner May be dispensed on the oral prescription of a practitioner in an emergency as authorized by federal law Must be promptly reduced to writing Schedule II prescriptions for patients in a long term care facility and terminally ill patients shall be valid for a period not to exceed 60 days from the date of issue unless terminated sooner by discontinuation of the medication Schedule II prescriptions cannot be refilled Schedule III, IV and V Prescribing Limitations (not related to pain clinics) Schedule III and IV substances may only be dispensed on the written or oral prescription of a practitioner Schedule III and IV prescriptions may not be filled or refilled more than six months after issued or refilled more than five times No prescription drug order may be filled or refilled more than twelve months after originally issued Miscellaneous Prescribing/Dispensing Requirements Dispensing practitioners shall reduce all drug orders to a written prescription that shall be numbered and filed in an organized manner when dispensed Patient medical records do not qualify as a prescription record Dispensing practitioners shall keep a file at each location from which dispensing takes place of drugs received, administered, dispensed, sold, or distributed Record shall be maintained for at least two years Shall include: A record or invoice of all drugs received for purposes of dispensing to patients A prescription record of drugs dispensed, filed by prescription number or date, showing the patient s name and address, date of prescription, name of the drug, strength of the drug, quantity dispensed, directions for use, signature of practitioner, and, if it s a controlled substance, the DEA number A record of refills showing date of refill, quantity dispensed, and initials of dispenser Patient profile if all data is not already included in the patient s chart Patient profile includes name, address, telephone number, date of birth, age, gender; individual history where significant, including disease state or states, known allergies and drug reactions, and a comprehensive list of medications and relevant devices being used showing the prescription number, the name and strength of the drug or device, the quantity and date received by the patient, and the name of the prescriber 2
3 Miscellaneous Prescribing/Dispensing Requirements, cont d. Prescriptions must contain the following information: Name and address of patient Amount of the substance to be compounded or dispensed with directions for use The signature, address, and federal registry number of the prescriber and a designation of the branch of the healing arts pursued by the prescriber The date when signed by the prescriber, or the date of acceptance by the pharmacy if an oral prescription Prescribing/Dispensing Limitations for Dentists Dentists may prescribe, administer, and dispense a controlled substance in Schedules II V within the expressed legal scope of the person s practice Prescribing/Dispensing Limitations for Optometrists Optometrists may prescribe, administer, and dispense a controlled substance in Schedules IV and V in the course of professional practice Pain Clinic/Pain Management Regulations Intractable pain means a pain state in which the cause of the pain cannot be removed or otherwise treated with the consent of the patient and in which no relief or cure for the cause of the pain is possible, or none has been found after reasonable efforts Reasonable efforts include, but are not limited to, the following: When treating a non-terminally ill patient for intractable pain, evaluation by the attending physician and one or more physicians specializing in pain medicine or the treatment of the area, system, or organ of the body perceived as the source of the pain When treating a terminally ill patient, evaluation by the attending physician who does so in accordance with the level of skill, care, and treatment that would be recognized by a reasonably prudent physician under similar conditions and circumstances A physician may prescribe or administer a controlled substance in Schedules II V to an individual in the course of the physician s treatment of the individual for a diagnosed condition causing intractable pain Must keep records of the purpose, use, prescription, and disposal of controlled substances Must write accurate prescriptions Physician shall discuss the risks and benefits of the use of controlled substances for the treatment of pain with the patient prior to prescribing or administering any controlled substance and document such discussion in the patient s record Training or Education Requirements or Recommendations for Practitioners who Prescribe or Dispense Controlled Substances No specific statutes or regulations identified. 3
4 Medical Marijuana or Controlled Substances Therapeutic Research Program Provisions This section deals only with the conditions that qualify a patient for the use of medical marijuana or a therapeutic research program and the attendant physician responsibilities. For complete information on state medical marijuana and therapeutic research programs, please visit the NAMSDL website at THC Therapeutic Research Act Establishment of extensive research program to investigate and report on the therapeutic effects of THC under strictly controlled circumstances Not intended to condone or promote the illicit recreational use of marijuana Commissioner shall grant funds to the principal investigator selected by the commissioner for the purpose of conducting a research program under a protocol approved by the FDA regarding the therapeutic use of oral THC and other dosage forms, if available The principal investigator shall: Allow each oncologist who meets or agrees to meet the requirements for investigational new drug research and who so requests to be included in the research program as a clinical investigator to conduct clinical trials Apply to contract with the National Institute on Drug Abuse for receipt of dosage forms of THC, fully characterized as to contents and delivery to the human system, pursuant to regulations Submit periodic reports Qualifying medical condition includes: Cancer, if the underlying condition or treatment produces one or more of the following: Severe or chronic pain Glaucoma HIV/AIDS Tourette s syndrome Amyotrophic lateral sclerosis Seizures, including those characteristic of epilepsy Severe and persistent muscle spasms, including those characteristic of multiple sclerosis Crohn s disease Terminal illness, with a probable life expectancy of under one year, if the illness or the treatment produces one or more of the following: Severe or chronic pain Nausea or severe vomiting Cachexia or severe wasting Any other medical condition or its treatment approved by the commissioner Prior to a patient s enrollment in the registry program, a health care practitioner shall: Determine, in the practitioner s medical judgment, whether a patient suffers from a qualifying medical condition and, if so determined, provide the patient with a certification of that diagnosis Determine whether a patient is developmentally or physically disabled and, if so, whether that renders the patient incapable of self-administering the medication or acquiring medical cannabis from a distribution facility and, if so determined, include that determination on the patient s certification of diagnosis 4
5 Medical Marijuana or Controlled Substances Therapeutic Research Program Provisions, cont d. Advise patients, registered designated caregivers, and parents or legal guardians who are acting as caregivers of the existence of any nonprofit patient support groups or organizations Provide explanatory information from the commissioner to patients with qualifying medical conditions, including disclosure to patients of the experimental nature of the therapeutic use of cannabis; the possible risks, benefits, and side effects of the proposed treatment; the application and other materials from the commissioner; and provide patients with the Tennessan warning Agree to continue treatment of the patient s qualifying medical condition and report medical findings to the commissioner Upon notification from the commissioner of a patient s enrollment in the registry program, the health care practitioner shall: Participate in the patient registry reporting system under the guidance and supervision of the commissioner Report health records of the patient throughout ongoing treatment of the patient to the commissioner in a manner determined by the commissioner and in accordance with law Determine, on an annual basis, if the patient continues to suffer from a qualifying medical condition and, if so, issue the patient a new certification of that diagnosis Otherwise comply with all requirements developed by the commissioner Health care practitioners are not subject to any civil or disciplinary penalties by any professional licensing board solely for participation in the registry program PMP Requirements for Mandatory Registration and Access If a medication used for the treatment of opioid addiction is administered or dispensed to a client, the licensee shall be subject to the following requirements: Upon admission to a methadone clinic outpatient treatment program, clients must be notified in writing that the commissioner of human services and the medical director will monitor the PMP to review the prescribed controlled drugs the clients have received The medical director or director s delegate must review the data from the PMP prior to the client being ordered any controlled substance, including medications used for the treatment of opioid addiction, and subsequent reviews of the PMP must occur at least once every 90 days When the PMP data contains a recent history of multiple prescribers or multiple prescriptions for controlled substances, the physician s review of the data and subsequent actions must be documented in the client s individual file within 72 hours and must contain the medical director s determination of whether or not the prescriptions place the client at risk of harm and the actions to be taken in response to the PMP findings Additionally, the provider must conduct subsequent reviews of the PMP on a monthly basis 5
6 Patient Referral to Treatment No specific statutes or regulations identified. Board Guidelines None. 6
Vermont. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Vermont Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of
Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
MINNESOTA S MEDICAL CANNABIS PROGRAM
MINNESOTA S MEDICAL CANNABIS PROGRAM DARIN TESKE LEGAL AND POLICY ADVISOR OFFICE OF MEDICAL CANNABIS AUGUST 25, 2016 2014: MN became 22 nd state with full medical cannabis program Recreational and Medical
MEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA MINNESOTA ACADEMY OF PHYSICIAN ASSISTANTS MARCH 18, 2016 TOM ARNESON, MD, MPH MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for
MEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA EPILEPSY & SEIZURES WELLNESS EXPO APRIL 16, 2016 MICHELLE LARSON, MPA MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program State
On December 27, 2017, the Lieutenant Governor signed into law several new requirements
OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following
OREGON MEDICAL MARIJUANA ACT
OREGON MEDICAL MARIJUANA ACT 475.300 Findings. The people of the state of Oregon hereby find that: (1) Patients and doctors have found marijuana to be an effective treatment for suffering caused by debilitating
CHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 1030
CHAPTER 2014-157 Committee Substitute for Committee Substitute for Senate Bill No. 1030 An act relating to cannabis; providing a short title; creating s. 381.986, F.S.; defining terms; authorizing specified
KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998
KANSAS Kansas State Board of Healing Arts Source: Kansas State Board of Healing Arts Approved: October 17, 1998 GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF PAIN Section 1: Preamble
SOUTH DAKOTA BOARD OF REGENTS. Policy Manual
SUBJECT: Drug Free Environment NUMBER: 4:27 SOUTH DAKOTA BOARD OF REGENTS Policy Manual Drug Free Workplace Policy The South Dakota Board of Regents is committed to providing a drug free workplace. Additional
Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain
Substances for the Treatment of Pain Effective January 2007, the Board of Healing Arts appointed a Task Force to review the current statutes, rules and guidelines regarding the treatment of pain. This
Minnesota Medical Cannabis Program. October 24, 2017
Minnesota Medical Cannabis Program October 24, 2017 Agenda: Overview of Minnesota Medical Cannabis Program Conditions, roles, products Laboratory Issues Program Evaluation * indicates a hyper-link to website
Article XIX DENTAL HYGIENIST COLLABORATIVE CARE PROGRAM
Article XIX DENTAL HYGIENIST COLLABORATIVE CARE PROGRAM Pursuant to ACA 17-82-701-17-82-707 the Arkansas State Board of Dental Examiners herby promulgates these rules to implement the dental hygienist
PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:
PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: / / Gender: Male Female Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell: Email: Primary
States with Authority to Require Nonresident Pharmacies to Report to PMP
States with Authority to Require Nonresident Pharmacies to Report to PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug
North Dakota Board of Pharmacy
North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives
Appendix F Federation of State Medical Boards
Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction
State, District, or Territory Criteria for Mandatory Query of PDMP
State, District, or Territory Alabama Alaska Arizona Criteria for Mandatory Query of PDMP Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance
Substance Abuse Policy. Substance Abuse Policy for Employees and Students
College Rules and Regulations 2.2008.1 Substance Abuse Policy Substance Abuse Policy for Employees and Students I. Substance Abuse Policy for Employees and Students A. Purpose The County College of Morris
INITIAL PATIENT INTAKE FORM
INITIAL PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only.
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW HOUSE BILL 243
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW 2017-74 HOUSE BILL 243 AN ACT STRENGTHENING OPIOID MISUSE PREVENTION BY EXTENDING STANDING ORDERS FOR OPIOID ANTAGONIST TO COMMUNITY HEALTH GROUPS;
ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH
ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH 1.0 INTRODUCTION Arkansas State University (ASU) is committed to enhancing the growth of research and other
From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016
From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016 OSBA leads the way to educational excellence by serving Ohio s public
Naloxone Access Statutes
Naloxone Access Statutes Research current through March 1, 2016 This project was supported by Grant No. G15599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions
Guideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
Dear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good
PAIN MEDICINE Volume 5 Number 3 2004,* Edward Covington, MD, and Patricia M. Good *Georgetown University, Washington, District of Columbia; Cleveland Clinic Foundation, Cleveland, Ohio; Office of Diversion
Medical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014
Medical Marijuana and Student Health New England College Health Association Gordon H. Smith, Esq. October 30, 2014 Medical Marijuana Laws Alaska (1998) Arizona (1996, 2010) California (1996) Colorado (2000)
CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION
CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION SECTION I PURPOSE AND AUTHORITY A. REGULATORY AUTHORITY 1. These rules shall be known as the Arkansas Department of Education and Arkansas State Board of
SECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
Prepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
Be it enacted by the People of the State of Illinois,
SB Enrolled LRB0 0 RPM 0 b AN ACT concerning public health. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section. The Compassionate Use of Medical Cannabis
NC General Statutes - Chapter 90 Article 5E 1
Article 5E. North Carolina Controlled Substances Reporting System Act. 90-113.70. Short title. This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System
APPLICATION TO EMPLOY A
STATE OF CALIFORNIA - STATE AND CONSUMER SERVICES AGENCY ARNOLD SCHWARZENEGGER, Governor BOARD OF PSYCHOLOGY 2005 Evergreen Street, SUITE 1400 SACRAMENTO, CA 95815-3831 (916) 263-2699 ext. 3303 www.psychboard.ca.gov
Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx
Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services
Scottsdale Certification Center Health History Questionnaire. Name Gender M / F Date. Date of Birth / / Phone Ht: ft in Wt. Residential Address
Scottsdale Certification Center Health History Questionnaire Name Gender M / F Date Date of Birth / / Phone Ht: ft in Wt Email Residential Address City State Zip Code Drivers Licence # Date Issued Mailing
The Legalization of Medical Marijuana and the Impact on the Workplace
The Legalization of Medical Marijuana and the Impact on the Workplace Presented by Cassandra L. Manna Thursday, October 12, 2017 Roetzel & Andress LPA 2016 Before We Get Started... Three Rules Supreme
COMIRB Protocol Number: PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH. Dear Fellow Medical Student,
COMIRB Protocol Number: 13-2387 PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH Dear Fellow Medical Student, We are conducting a study to assess the attitudes and experiences of medical
MEDICAL MARIJUANA USE
AOM Chapter P-158 MEDICAL MARIJUANA USE GENERAL CONSIDERATIONS AND GUIDELINES: Massachusetts voters decided that this Commonwealth should join a growing number of other states that currently have laws
131. Public school enrollees' immunization program; exemptions
TITLE 14. EDUCATION PART I. FREE PUBLIC SCHOOLS CHAPTER 1. DEPARTMENT OF EDUCATION SUBCHAPTER II. POWERS AND DUTIES 14 Del. C. 131 (2007) 131. Public school enrollees' immunization program; exemptions
PHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL
PHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL NOVEMBER 2017 CSHCN PROVIDER PROCEDURES MANUAL NOVEMBER 2017 PHYSICAL MEDICINE AND REHABILITATION Table of Contents 30.1 Enrollment......................................................................
Alcohol and Drug Testing for Employees with Commercial Drivers' License
Alcohol and Drug Testing for Employees with Commercial Drivers' License Revised: 02/12 FSS/PPS 04.05.04 Issue No. 5 Reviewer: Director, Facilities Management Effective Date: 01/01/96 (E4Y) Review Date:
CHAPTER Section 3 of P.L.1983, c.296 (C.45: ) is amended to read as follows:
CHAPTER 121 AN ACT concerning the practice of physical therapy, amending P.L.2003, c.18, and amending and supplementing P.L.1983, c.296. BE IT ENACTED by the Senate and General Assembly of the State of
Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator
Medical Cannabis Program Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator Disclaimer The following information is based upon research of current studies. The Department of Health
FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine
FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine
Naloxone Access Statutes
Naloxone Access Statutes Research current through August 30, 2015 This project was supported by Grant No. G15599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions
ASA Model Legislation (updated July 2014)
ASA Model Legislation (updated July 2014) WHEREAS cannabis has been used as a medicine for at least 5,000 years and can be effective for serious medical conditions for which conventional medications fail
DOUGLAS COUNTY GOVERNMENT POLICY FORM. To ensure a drug-free work environment within Douglas County Government.
DOUGLAS COUNTY GOVERNMENT POLICY FORM SUBJECT DRUG-FREE WORKPLACE TITLE DRUG-FREE WORKPLACE POLICY NO. HR.6.10 APPROVAL DATE 1/1/11 REVISION DATE 1/16/18 PURPOSE: DEPARTMENT RESPONSIBLE: DEPARTMENT(S)
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2013 H 1 HOUSE BILL 933. Short Title: Informed Consent for HIV/AIDS Testing. (Public)
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 01 H 1 HOUSE BILL Short Title: Informed Consent for HIV/AIDS Testing. (Public) Sponsors: Referred to: Representatives Mobley and Farmer-Butterfield (Primary Sponsors).
Smoke and Mirrors: Navigating Medical Marijuana in the Workplace
Smoke and Mirrors: Navigating Medical Marijuana in the Workplace Douglas P. Currier Elizabeth Connellan Smith dcurrier@verrilldana.com esmith@verrilldana.com (207) 253-4450 (207) 253-4460 Some Statistics
INITIAL PRACTICE PERIOD FORMS
INITIAL PRACTICE PERIOD FORMS 5060-3080 Yonge Street, Box 71 Toronto, Ontario M4N 3N1 416-975-5347 1-800-993-9459 www.caslpo.com Revised: May 2017 TABLE OF CONTENTS 1 MENTORSHIP GUIDANCE CONTRACT 3 2 1
Use of Controlled Substances in Research.
3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible
4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP
New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6
ORDINANCE NO
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF ORLANDO, FLORIDA, RELATING
AN ACT. relating to the medical use of low-thc cannabis and the regulation. of related organizations and individuals; requiring a dispensing
Chapter 0 S.B. No. AN ACT relating to the medical use of low-thc cannabis and the regulation of related organizations and individuals; requiring a dispensing organization to obtain a license to dispense
Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for
This document is scheduled to be published in the Federal Register on 12/13/2017 and available online at https://federalregister.gov/d/2017-26785, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
77th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 3460
77th OREGON LEGISLATIVE ASSEMBLY--2013 Regular Session Enrolled House Bill 3460 Sponsored by Representative BUCKLEY, Senator PROZANSKI; Representative FREDERICK, Senator DINGFELDER CHAPTER... AN ACT Relating
H 7816 S T A T E O F R H O D E I S L A N D
LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, Canario,
CDL Drivers Controlled Substance and Alcohol Policy
CDL Drivers Controlled Substance and Alcohol Policy Section 1. General. It is the purpose of this policy to encourage an enlightened viewpoint toward alcoholism and other drug dependencies as behavioral/medical
Title 32: PROFESSIONS AND OCCUPATIONS
Title 32: PROFESSIONS AND OCCUPATIONS Chapter 45-A: PHYSICAL THERAPIST PRACTICE ACT Table of Contents Section 3111. DEFINITIONS... 3 Section 3111-A. SCOPE OF PRACTICE... 3 Section 3112. BOARD CREATED;
Employee Substance Abuse Program
Employee Substance Abuse Program ConocoPhillips Canada June 2011 1 Table of Contents A. Introduction. 3 B. Interpretation. 3 C. Program Statement. 3 D. Supervisor Responsibilities 5 E. Support for ConocoPhillips
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL D IRECTOR EMERGENCY C A R E ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE
The West Virginia Medical Cannabis Act
The West Virginia Medical Cannabis Act Brian J. Skinner General Counsel, Bureau for Public Health WV Medical Cannabis Advisory Board Meeting Charleston, West Virginia August 16, 2017 West Virginia Medical
MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent
MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent Pain may be effectively managed through the use of controlled substance medications (referred to below as opioids
OFFICIAL POLICY. Policy Statement
OFFICIAL POLICY 9.1.6 Employee Drug and Alcohol Abuse Policy 2/8/16 Policy Statement Employee Drug and Alcohol Abuse Policy #CofC.HR.DA.03 Revised 12/2001 The Drug-Free Schools and Communities Act The
Antidepressants for treatment of depression.
JR3 340 1 of 9 PSYCHOTROPIC MEDICATIONS PURPOSE The use of psychotropic medication as part of a youth's comprehensive mental health treatment plan may be beneficial. The administration of psychotropic
ARIZONA MEDICAL MARIJUANA PROGRAM. Tina Wesoloskie, MPA Office of Medical Marijuana Card Registry Arizona Department of Health Services
ARIZONA MEDICAL MARIJUANA PROGRAM Tina Wesoloskie, MPA Office of Medical Marijuana Card Registry Arizona Department of Health Services Learning Objectives: List two medical conditions that qualify for
Opioid Management of Chronic (Non- Cancer) Pain
Optima Health Opioid Management of Chronic (Non- Cancer) Pain Guideline History Original Approve Date 5/08 Review/Revise Dates 11/09, 9/11, 9/13, 09/15, 9/17 Next Review Date 9/19 These Guidelines are
MARY JANE ON CAMPUS? EMPLOYEE AND STUDENT USE OF MEDICAL MARIJUANA APPLICABLE LAWS CONTROLLED SUBSTANCES ACT
MARY JANE ON CAMPUS? EMPLOYEE AND STUDENT USE OF MEDICAL MARIJUANA By: Evelyn Howard-Hand and Linda M. Trujillo 500 Marquette Avenue NW, Suite 1360 Albuquerque, New Mexico 87102 Phone: 505-243-6864 APPLICABLE
Request for Proposal. PA ACT 139 Naloxone Purchase
Request for Proposal PA ACT 139 Naloxone Purchase Proposals due by February 6, 2014, 4:00PM 3905 N. Front Street Harrisburg, PA 17110-1536 Phone (717) 236-1059 Table of Contents PA ACT 139... I NALOXONE
The purpose of this rule is to clarify the special practice authorities addressed in , C.R.S.
DEPARTMENT OF REGULATORY AGENCIES Physical Therapy Licensure COLORADO PHYSICAL THERAPY LICENSURE RULES AND REGULATIONS 4 CCR 732-1 [Editor s Notes follow the text of the rules at the end of this CCR Document.]
Instructions for Applicants. Successful completion of this examination is required as one of the conditions for licensure in the State of Vermont.
Board of Dental Examiners Page 1 - Rev. 05/2010 Instructions for Applicants Successful completion of this examination is required as one of the conditions for licensure in the State of Vermont. 1. Use
Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance
19 TH JUDICIAL DUI COURT REFERRAL INFORMATION
19 TH JUDICIAL DUI COURT REFERRAL INFORMATION Please review the attached DUI Court contract and Release of Information. ******* You must sign and hand back to the court the Release of Information today.
City Commission Agenda Cover Memorandum
City Commission Agenda Cover Memorandum Originating Department: Planning & Zoning (PZ) Meeting Type: Regular Agenda Date: 10/10/2017 Advertised: Required?: Yes No ACM#: 21615 Subject: Public Hearing and
AN ACT RELATING TO HEALTH CARE; ENACTING THE UNLICENSED HEALTH CARE BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
AN ACT RELATING TO HEALTH CARE; ENACTING THE UNLICENSED HEALTH CARE PRACTICE ACT; PROVIDING PENALTIES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO: Section 1. SHORT TITLE.--This act may
NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS (NAMSDL) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT-
NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS (NAMSDL) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT- REVISED 11-22-13 NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS (NAMSDL) MODEL PRESCRIPTION MONITORING
Adopted May 3, 2011 by Apache County Board of Supervisors Draft for P & Z Commission December 2015
2300 Section 2301. Definitions Medical Marijuana Designated Caregiver Cultivation Location An enclosed facility, that does not exceed 250 square feet of cultivation space, where a designated caregiver,
Legislative Counsel s Digest:
Senate Bill No. 250 Senator Carlton (by request) CHAPTER... AN ACT relating to dentistry and dental hygiene; revising various provisions governing the qualifications, examination and licensure of dentists
OPIOID PAIN MEDICATION Agreement and Informed Consent
OPIOID PAIN MEDICATION Agreement and Informed Consent I. Introduction Research and clinical experience show that opioid (narcotic) pain medications are helpful for some patients with chronic pain. The
BCC DENTAL HYGIENE DEPARTMENT PATIENT S RIGHTS AND CONSENT PACKET STANDARDS OF PATIENT CARE PATIENT S RIGHTS FOR DH CARE
BCC DENTAL HYGIENE DEPARTMENT PATIENT S RIGHTS AND CONSENT PACKET STANDARDS OF PATIENT CARE PATIENT S RIGHTS FOR DH CARE PATIENT S AGREEMENT POLICY FOR TREATMENT HIPAA NOTICE OF PRIVACY PRACTICES / CONSENT
AVEDA FREDRIC S INSTITUTE DRUG FREE SCHOOL POLICY
AVEDA FREDRIC S INSTITUTE DRUG FREE SCHOOL POLICY The Aveda Fredric s Institute believes that it is very important to provide a safe environment for all of its students and Team Members. Substance abuse,
COLORADO PRESCRIPTION DRUG MONITORING PROGRAM
COLORADO PRESCRIPTION DRUG MONITORING PROGRAM Harold Rogers Prescription Drug Monitoring Program West Regional Meeting Salt Lake City, Utah August 12 13, 2014 Tia Stakely, M.S. PDMP Administrator 2005
Sacrament of Confirmation Registration Form Year 2 St. Cornelius Catholic Church
Sacrament of Confirmation Registration Form Year 2 St. Cornelius Catholic Church 2017-2018 (Please type or print clearly) Name of Candidate: Age: Address: Street City Zip Home Phone: ( ) Cell or other:
Updated: 08/2017 DMMA Approved: 11/2017
Request for Prior Authorization for Therapy to Treat Binge Eating Disorder Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for medications to treat Binge
I MINA' TRENTI DOS NA LIHESLATURAN GUAHAN 2013 (FIRST) Regular Session
I MINA' TRENTI DOS NA LIHESLATURAN GUAHAN 2013 (FIRST) Regular Session Bill No. :t tl.-- '3J-(lP'( \ J Introduced by: \\ 't T.R. Mufia Barnes'" / ~ f A.A.Yamashita, Ph.D@~ u AN ACT TO ADD A NEW ARTICLE
Senate File Introduced
Senate File 0 - Introduced SENATE FILE 0 BY COMMITTEE ON WAYS AND MEANS (SUCCESSOR TO SSB ) A BILL FOR An Act creating the medical cannabidiol Act and providing penalties and including effective date provisions.
Marijuana - Medicinal Use: Bill Status Update
Marijuana - Medicinal Use: Bill Status Update Research current through February 9, 2015. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices
Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining
LUNCH AND LEARN. January 8, CE Activity Information & Accreditation
LUNCH AND LEARN Pharmacy Law: The Ins and Outs of Controlled Substances January 8, 2016 Featured Speaker: Joseph J. Bogdan, Pharm.D., R.Ph., J.D. Pharmacist Attorney Lisle, Illinois 1 CE Activity Information
DMHAS ASAM SERVICE DESCRIPTIONS
(DMHAS) Fee for Service (FFS) ANNEX A1 DMHAS ASAM SERVICE DESCRIPTIONS Please carefully review the Service Descriptions that are included in the DMHAS FFS Initiatives in this Annex A1 contract section.
DEKALB COUNTY GOVERNMENT DRUG-FREE WORKPLACE POLICY
DEKALB COUNTY GOVERNMENT DRUG-FREE WORKPLACE POLICY Reviewed For Updates March 1, 2017 DeKalb County Government Drug-Free Workplace Policy CURRENT DATE OF CONTENTS OF DRUG-FREE WORKPLACE POLICY Pg. Section
Act 16 and Medical Cannabis in Pennsylvania
Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health
Legal Issues in Opioid Prescribing
Legal Issues in Opioid Prescribing Joanne L. Martin, J.D. Legal Counsel Mayo Clinic Rochester, Mn 2015 MFMER slide-1 Conflict of Interest I have no relevant financial relationships to disclose I will not
Requirements for Nurse Practitioners to Prescribe Buprenorphine-Naloxone (Suboxone):
Nurse Practitioner Change in Scope of Practice: Education and Practice Requirements for Nurse Practitioners (NPs) to Prescribe Buprenorphine-Naloxone (Suboxone) and Methadone On October 20 th, 2017, ARNNL